OGN
NYSE · Pharmaceuticals
Organon & Co
$13.68
-0.01 (-0.07%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+29.42%
YTD
+88.95%
Open$13.68
Previous Close$13.69
Day High$13.70
Day Low$13.68
52W High$13.79
52W Low$5.69
Volume—
Avg Volume2.80M
Market Cap3.60B
P/E Ratio17.21
EPS$0.78
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$7.87
Above
SMA 200
$8.85
Above
RSI (14)
32.1
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Sell
13 analysts
Price Target
+560.8% upside
Current
$13.68
$13.68
Target
$90.40
$90.40
$73.92
$90.40 avg
$125.40
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 6.29B | 6.27B | 515.23M |
| Net Income | 189.08M | 169.78M | 144.40M |
| Profit Margin | 3.0% | 2.9% | 28.0% |
| EBITDA | 587.48M | 556.82M | 186.20M |
| Free Cash Flow | — | — | 113.95M |
| Rev Growth | +0.2% | +0.2% | +11.5% |
| Debt/Equity | 11.49 | 11.49 | 0.71 |
Dividend
Dividend Yield9.86%
Annual Dividend$0.34
Payout Ratio47.1%
Frequencyquarterly
Ex-DividendMar 29, 2026
Pay DateApr 18, 2026
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |